PetMed Express (PETS) Stock Price, News & Analysis

Company Overview

PetMed Express, Inc. operates as an online and catalog-based pet pharmacy and retail supplier under the 1-800-PetMeds brand name. The company distributes prescription and non‐prescription medications, nutritional supplements, flea and tick control products, and a range of pet health supplies directly to consumers. Through its licensed veterinary pharmacy in Delray Beach, Florida, PetMed Express fills orders for dogs, cats and other companion animals, offering both branded and generic products alongside its own private‐label formulations.

Founded in 1996 by Marc Puleo, PetMed Express built its business on the premise of convenience and cost savings for pet owners seeking reliable access to veterinary medications. The company launched its initial public offering in 2000 and has since developed an in‐house team of veterinarians and pharmacy professionals to review prescriptions and provide customer support. With a multi‐channel approach that includes online ordering, telephone service and direct mail catalogs, PetMed Express seeks to simplify the process of obtaining essential pet health products.

PetMed Express primarily serves customers across the United States, with select offerings available in Canada. Its operations center around a fulfillment facility in Florida, supported by a network of third‐party carriers for nationwide delivery. The company is led by its founder and Chief Executive Officer, Marc Puleo, who oversees strategy and business development alongside a management team experienced in pharmaceutical distribution and e-commerce. PetMed Express continues to focus on expanding its product portfolio, enhancing digital capabilities and maintaining compliance with regulatory standards in veterinary pharmacy.

Key Stats

• Today's Range: $1.75 to $1.78
• 50-Day Range: $1.75 to $2.05
• 52-Week Range: $1.57 to $4.10
• Volume: 50,347 shs
• Average Volume: 101,974 shs
• Market Capitalization: $38.16 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: Reduce

PetMed Express Stock Analysis - MarketRank™

PetMed Express scored higher than 27% of companies evaluated by MarketBeat, and ranked 390th out of 485 stocks in the consumer discretionary sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 1.0 / 5
• Analyst Rating: Reduce

Consensus Rating

PetMed Express has received a consensus rating of Reduce. The company's average rating score is 1.50, and is based on no strong buy ratings, no buy ratings, 1 hold rating, and 1 sell rating.

Amount of Analyst Coverage

PetMed Express has only been the subject of 1 research reports in the past 90 days.

Earnings and Valuation

• Score: 1.9 / 5
• Proj. Earnings Growth: 28.57%

Earnings Growth

Earnings for PetMed Express are expected to grow by 28.57% in the coming year, from $0.07 to $0.09 per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of PetMed Express is -1.28, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of PetMed Express is -1.28, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Book Value per Share Ratio

PetMed Express has a P/B Ratio of 1.66. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

Short Interest

• Score: 4.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

3.12% of the float of PetMed Express has been sold short.

Short Interest Ratio / Days to Cover

PetMed Express has a short interest ratio ("days to cover") of 6.82.

Change versus previous month

Short interest in PetMed Express has recently decreased by 28.08%, indicating that investor sentiment is improving significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: Weak

Dividend Yield

PetMed Express does not currently pay a dividend.

Dividend Growth

PetMed Express does not have a long track record of dividend growth.

Dividend Sustainability

Based on EPS estimates, PetMed Express will have a dividend payout ratio of 1,000.00% in the coming year. This indicates that PetMed Express may not be able to sustain their current dividend.

News and Social Media

• Score: 1.4 / 5
• News Sentiment: 0.21

News Sentiment

PetMed Express has a news sentiment score of 0.21. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.62 average news sentiment score of Consumer Discretionary companies.

News Coverage This Week

MarketBeat has tracked 2 news articles for PetMed Express this week, compared to 2 articles on an average week.

Search Interest

Only 1 people have searched for PETS on MarketBeat in the last 30 days. This is a decrease of -80% compared to the previous 30 days.

Company Ownership

• Score: 0.8 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, PetMed Express insiders have not sold or bought any company stock.

Percentage Held by Insiders

1.30% of the stock of PetMed Express is held by insiders.

Percentage Held by Institutions

73.33% of the stock of PetMed Express is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

Company Calendar

• Last Earnings: 8/13/2026
• Today: 8/22/2026
• Next Earnings (Estimated): 10/13/2026
• Fiscal Year End: 3/31/2027

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Consumer Discretionary
• Industry: Specialty Retail
• Sub-Industry: Other Specialty Retail
• Current Symbol: NASDAQ:PETS
• CIK: 1040130
• Web: www.1800petmeds.com
• Phone: (561) 526-4444
• Fax: 561-526-4445
• Employees: 210
• Year Founded: 1996

Profitability

• EPS (Trailing Twelve Months): ($1.38)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: 25.14
• P/E Growth: N/A
• Net Income: -$57.29 million
• Net Margins: -17.34%
• Pretax Margin: -17.38%
• Return on Equity: -91.69%
• Return on Assets: -35.15%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 0.68
• Quick Ratio: 0.47

Sales & Book Value

• Annual Sales: $168.86 million
• Price / Sales: 0.23
• Cash Flow: $0.31 per share
• Price / Cash Flow: 5.69
• Book Value: $1.06 per share
• Price / Book: 1.66

Miscellaneous

• Outstanding Shares: 21,679,000
• Free Float: 21,397,000
• Market Cap: $38.16 million
• Optionable: Optionable
• Beta: 0.76